EE200300515A - Arüülsulfoonamiidid kui viirusevastased ained - Google Patents

Arüülsulfoonamiidid kui viirusevastased ained

Info

Publication number
EE200300515A
EE200300515A EEP200300515A EEP200300515A EE200300515A EE 200300515 A EE200300515 A EE 200300515A EE P200300515 A EEP200300515 A EE P200300515A EE P200300515 A EEP200300515 A EE P200300515A EE 200300515 A EE200300515 A EE 200300515A
Authority
EE
Estonia
Prior art keywords
arylsulfonamides
antiviral agents
antiviral
agents
Prior art date
Application number
EEP200300515A
Other languages
English (en)
Estonian (et)
Inventor
Wunberg Tobias
Bender Wolfgang
Eckenberg Peter
Hallenberger Sabine
Henninger Kerstin
Keldenich J�Rg
Kern Armin
Raddatz Siegfried
Reefschl�ger J�rgen
Schmidt Gunter
Zimmermann Holger
Zumpe Franz
Radtke Martin
Original Assignee
Bayer Aktiengeshellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10148598A external-priority patent/DE10148598A1/de
Application filed by Bayer Aktiengeshellschaft filed Critical Bayer Aktiengeshellschaft
Publication of EE200300515A publication Critical patent/EE200300515A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
EEP200300515A 2001-04-19 2002-04-08 Arüülsulfoonamiidid kui viirusevastased ained EE200300515A (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10119137 2001-04-19
DE10148598A DE10148598A1 (de) 2001-04-19 2001-10-02 Neue Arylsulfonamide als antivirale Mittel
PCT/EP2002/003858 WO2002085869A1 (de) 2001-04-19 2002-04-08 Arylsulfonamide als antivirale mittel

Publications (1)

Publication Number Publication Date
EE200300515A true EE200300515A (et) 2004-02-16

Family

ID=26009118

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200300515A EE200300515A (et) 2001-04-19 2002-04-08 Arüülsulfoonamiidid kui viirusevastased ained

Country Status (20)

Country Link
US (1) US7115612B2 (enExample)
EP (1) EP1383749B1 (enExample)
JP (1) JP4480941B2 (enExample)
CN (1) CN1516695A (enExample)
AT (1) ATE308529T1 (enExample)
BG (1) BG108272A (enExample)
BR (1) BR0209054A (enExample)
CA (1) CA2444123C (enExample)
DE (1) DE50204780D1 (enExample)
EE (1) EE200300515A (enExample)
ES (1) ES2252455T3 (enExample)
HU (1) HUP0303813A3 (enExample)
IL (1) IL158324A0 (enExample)
MX (1) MXPA03009548A (enExample)
NO (1) NO20034667L (enExample)
PL (1) PL363990A1 (enExample)
RU (1) RU2003133750A (enExample)
SK (1) SK12662003A3 (enExample)
UY (1) UY27263A1 (enExample)
WO (1) WO2002085869A1 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20050168A2 (en) * 2002-08-23 2005-10-31 Rigel Pharmaceuticals Pyridyl substituted heterocycles useful for treating or preventing hcv infection
DE10319612A1 (de) 2003-05-02 2004-11-18 Bayer Healthcare Ag Substituierte Dihydrochinazoline
EP4101846B1 (en) 2003-04-11 2023-08-02 PTC Therapeutics, Inc. 1,2,4-oxadiazole benzoic acid compounds and their use for nonsense suppression and the treatment of disease
DE102006009928A1 (de) * 2006-03-03 2007-09-06 Aicuris Gmbh & Co. Kg Substituierte Arylsulfonamide
EP2387995A1 (en) 2006-03-30 2011-11-23 PTC Therapeutics, Inc. Methods for the production of functional protein from DNA having a nonsense mutation and the treatment of disorders associated therewith
US20080255203A1 (en) * 2007-04-12 2008-10-16 Abbott Laboratories Heterocyclic compounds and their methods of use
CA2692379A1 (en) * 2007-07-02 2009-01-08 Boehringer Ingelheim International Gmbh Antiproliferative compounds based on 5-membered heterocycles
EP2177521A1 (en) * 2008-10-14 2010-04-21 Almirall, S.A. New 2-Amidothiadiazole Derivatives
EP2202232A1 (en) * 2008-12-26 2010-06-30 Laboratorios Almirall, S.A. 1,2,4-oxadiazole derivatives and their therapeutic use
CN103119036B (zh) * 2010-06-28 2018-05-08 拜耳知识产权有限责任公司 作为杀虫剂的杂环化合物
JP2013531687A (ja) 2010-07-16 2013-08-08 パーデュー、ファーマ、リミテッド、パートナーシップ ナトリウムチャネル遮断剤としてのピリジン化合物
WO2013136170A1 (en) 2012-03-16 2013-09-19 Purdue Pharma L.P. Substituted pyridines as sodium channel blockers
US9284310B2 (en) 2012-11-03 2016-03-15 Boehringer Ingelheim International Gmbh Inhibitors of cytomegalovirus
EP2914592B1 (en) 2012-11-03 2017-10-11 Boehringer Ingelheim International GmbH Inhibitors of cytomegalovirus
EP2935257B1 (en) 2012-12-20 2018-02-07 Purdue Pharma LP Cyclic sulfonamides as sodium channel blockers
WO2015134711A1 (en) 2014-03-06 2015-09-11 Ptc Therapeutics, Inc. Pharmaceutical compositions and salts of a 1,2,4-oxadiazole benzoic acid
US10730866B2 (en) 2014-04-07 2020-08-04 Purdue Pharma L.P. Indole derivatives and use thereof
EP3256461B1 (en) * 2015-02-13 2023-09-13 Azienda Ospedaliera Universitaria Senese Urea and sulfonamide derivatives as human helicase ddx3 inhibitors useful in the treatment of viral diseases
TW201729807A (zh) 2015-10-30 2017-09-01 Ptc治療公司 用於治療癲癇的方法
EP3601274A1 (en) * 2017-03-31 2020-02-05 Perenna Pharmaceuticals, Inc. Compounds useful as inhibitors of alcat 1

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19802437A1 (de) 1998-01-23 1999-07-29 Bayer Ag Verwendung von substituierten Sulfonamiden als anitvirale Mittel und neue Stoffe
PL351374A1 (en) * 1999-04-19 2003-04-07 Shionogi & Co Sulfonamide derivatives having oxadiazole rings

Also Published As

Publication number Publication date
UY27263A1 (es) 2002-11-29
EP1383749B1 (de) 2005-11-02
DE50204780D1 (de) 2005-12-08
HUP0303813A3 (en) 2005-05-30
WO2002085869A1 (de) 2002-10-31
JP2004531536A (ja) 2004-10-14
JP4480941B2 (ja) 2010-06-16
RU2003133750A (ru) 2005-05-10
NO20034667D0 (no) 2003-10-17
ES2252455T3 (es) 2006-05-16
EP1383749A1 (de) 2004-01-28
CA2444123A1 (en) 2002-10-31
NO20034667L (no) 2003-12-12
US7115612B2 (en) 2006-10-03
CN1516695A (zh) 2004-07-28
HUP0303813A2 (hu) 2004-03-29
BR0209054A (pt) 2004-04-20
MXPA03009548A (es) 2004-05-24
BG108272A (bg) 2004-10-29
SK12662003A3 (sk) 2004-04-06
US20040176374A1 (en) 2004-09-09
ATE308529T1 (de) 2005-11-15
CA2444123C (en) 2010-09-21
PL363990A1 (en) 2004-11-29
IL158324A0 (en) 2004-05-12

Similar Documents

Publication Publication Date Title
EE200300437A (et) Triasolopüridiinid kui põletikuvastased ained
DE60318769D1 (de) Maskenüberzug
NO20034176L (no) Pyrazolopyrimidiner som terapeutiske midler
NO20034177L (no) Pyrazolopyrimidiner som terapeutiske midler
DE60216265D1 (de) Verbesserungen in spritzenhalterungen
NO20033205L (no) Terapeutiske kromanforbindelser
ATE473981T1 (de) Antivirale diazaindol-dicarbonyl- piperazinylmittel
NO20014597D0 (no) Fremgangsmåte
DK1373228T3 (da) Substituerede fluoralkoxyphenylsulfonylurinstoffer
NO20041066L (no) Hydroksyeikosensyre-analoger
EA200401429A1 (ru) Баня
IS7943A (is) Ný amínóbensófenónefnasambönd
DE50201532D1 (de) Gerätekonstruktion
DE10291166D2 (de) Anti-Schuppen-Mittel
FR2836809B1 (fr) Baignoire
PT102660B (pt) Novos agentes quelantes polidentados do tipo 3-hidroxi-4-piridinona
SE0103855D0 (sv) Therapeutic agents
SE0103854D0 (sv) Therapeutic agents
UA6364S (uk) Ванна бальнеологічна
SE0101435D0 (sv) Huvudskydd
NO20011527D0 (no) Spann
SE0200450D0 (sv) Therapeutic agents
SE0203826D0 (sv) Therapeutic agents
SE0203623D0 (sv) Simfena
SE0102893D0 (sv) Antivirals II

Legal Events

Date Code Title Description
HK1A Erratum in gazette